Billionaire-backed Juvenescence primes the anti-aging pipeline pump with a $12M seed round

Excerpt

<div>The biotech has started out with a pact with the AI experts at <b>Insilico Medicine</b>, who are providing molecules for development. Aside from the cellular pathways that have attracted their attention, the biotech will look to effect change in the mitochondria, the cell's powerhouse, as well as clean up senescent ...</div>